BioKier was one of five selected North Carolina biotech companies to present in the Innovation Showcase session at the 2014 CED Life Science Conference in Raleigh on February 26-27. The selection included an invitation to present to attendees a report on BioKier’s progress and plans for development of the company’s innovative therapeutic for type 2 diabetes. This was a great opportunity to present the company’s progress and plans for clinical development of our novel treatment for type 2 diabetes and a further recognition of BioKier’s standing in the North Carolina biotech community. BioKier connected with interested parties and continues discussions with several potential corporate partners.
Read more about BioKier at 2014 CED Life Science Conference in News & Observer article and Exit Event.